This study evaluates the possibility of increased risk of HCC during and after DAAs treatment in HCV patients with advanced liver disease.
Incidence and pattern of "de novo"hepatocellular carcinoma in HCV patients treated with oral DAAs,
CAPRA, Franco;CAROLO, Giada;SCROCCARO, GIOVANNA;
2016-01-01
Abstract
This study evaluates the possibility of increased risk of HCC during and after DAAs treatment in HCV patients with advanced liver disease.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
